Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
Clinics; 74 (), 2019
OBJECTIVES: To evaluate the effects of epoetin (EPO) alfa treatment on overall survival, event-free survival and response duration in patients with myelodysplastic syndrome (MDS) who were treated at a haematological referral centre in northeastern Brazil. METHODS: This was a retrospective cohort study o...
Transfusión Sanguínea, Brasil, Progresión de la Enfermedad, Epoetina alfa/uso terapéutico, Hematínicos/uso terapéutico, Hemoglobinas/análisis, Estimación de Kaplan-Meier, Cariotipo, Síndromes Mielodisplásicos/tratamiento farmacológico, Síndromes Mielodisplásicos/mortalidad, Recuento de Plaquetas, Supervivencia sin Progresión, Valores de Referencia, Estudios Retrospectivos, Factores de Riesgo, Factores de Tiempo, Resultado del Tratamiento